Activated macrophages are important effector cells for immune response
s to many parasites and immune responses are strongly modulated in par
t by the effect of Th cell-derived cytokines on macrophages. Th1-deriv
ed cytokines such as IFN-gamma are strong stimulators of macrophage ac
tivation, while cytokines produced by Th2 cells, including IL-4 and IL
-10, have been shown under some conditions to inhibit macrophage activ
ities associated with inflammatory responses. IL-13, a recently descri
bed cytokine produced by Th2 cells, is also capable of down-modulating
macrophage activity in a manner similar to that previously described
for IL-4. Treatment of activated macrophages with IL-13 reduces the pr
oduction of inflammatory monokines in response to IFN-gamma or LPS, bo
th potent stimulators of these factors. In addition, IL-13 decreases t
he production of nitric oxide by activated macrophages. Nitric oxide h
as been implicated in both macrophage cytotoxicity and macrophage-asso
ciated immunosuppression. The suppression of nitric oxide by IL-13 lea
ds to a decrease in parasiticidal activity by activated macrophages. H
owever, our data indicate that IL-13 has plieotropic effects, while th
e inflammatory potential of activated macrophages is significantly red
uced, the potential of other macrophage subsets is unimpaired. These d
ata indicate that IL-13 could be a potent modulator of immune response
s in vivo, with effects that may embrace both macrophage suppressive a
nd macrophage potentiating functions.